2025-04-19 07:43:38
Latest Post
Liberty Shoes Ltd announces revenue updates and Financial performance for Q4 & FY 2024-25
Mastek Ltd consolidated Q4 FY2024-25 net profit lower at Rs. 81.07 crores
Amal Ltd posts consolidated PAT of Rs. 6.77 crore in Q4FY25
Network18 Media and Investments Ltd posts consolidated Q4FY25 loss of Rs. 30.31 crores
Orosil Smiths India Ltd Q4 FY2025 PAT higher at Rs. 81.17 lakhs
Stock Report
SMS Pharmaceuticals Ltd reports consolidated net profit of Rs. 3.76 crore
Posted On : 2023-02-09 13:04:03( TIMEZONE : IST )
SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 151.0186 crores during the period ended December 31, 2022 as compared to Rs. 160.0465 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 3.7643 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -2.0084 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.44 for the period ended December 31, 2022 as compared to Rs. -0.24 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹151.0186 crs | ₹160.0465 crs |  -5.64% |
| Net Profit | ₹3.7643 crs | ₹-2.0084 crs |  287.43% |
| EPS | ₹0.44 | ₹-0.24 | 283.33% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.151.0186 crores during the period ended December 31, 2022 as compared to Rs.123.3834 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.3.7643 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.8.9626 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.44 for the period ended December 31, 2022 as compared to Rs.1.07 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹151.0186 crs | ₹123.3834 crs | 22.40% |
| Net Profit | ₹3.7643 crs | ₹8.9626 crs | -58.00% |
| EPS | ₹0.44 | ₹1.07 | -58.88% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.376.2551 crores during the 9 Months period ended December 31, 2022 as compared to Rs.463.7266 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-10.5699 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.55.8109 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.-1.25 for the 9 Months period ended December 31, 2022 as compared to Rs.6.59 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹376.2551 crs | ₹463.7266 crs | -18.86% |
| Net Profit | ₹-10.5699 crs | ₹55.8109 crs | -118.94% |
| EPS | ₹-1.25 | ₹6.59 | -118.97% |
Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 72.40 as compared to the previous close of Rs. 72.65. The total number of shares traded during the day was 2388 in over 134 trades.
The stock hit an intraday high of Rs. 73.25 and intraday low of 71.00. The net turnover during the day was Rs. 172722.00.
